Global Nephrology and Urology Devices Market Size Study, by Product Type, by Application, by End User and Regional Forecasts 2022-2032

Description

The Global Nephrology and Urology Devices Market was valued at USD 32.71 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2032. The market for nephrology and urology devices is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), chronic kidney disease is slightly more prevalent in women (14%) compared to men (12%). Consequently, the growing incidence of kidney diseases and other urological conditions has increased the demand for nephrology and urology devices, thereby propelling market growth during the forecast period. Additionally, increased awareness of the importance of early diagnosis and treatment of kidney and urology disorders has led to higher demand for screening and diagnostic devices, further driving the nephrology devices market growth. The American Kidney Fund supports policies to expand the use of chronic kidney disease screening and improve clinical research, provider training, and diagnosis and prevention of rare kidney diseases. Furthermore, the increasing demand for home-based dialysis solutions and portable devices provides a lucrative opportunity for the nephrology and urology devices market growth.

The rise in the incidence of conditions such as chronic kidney disease, kidney stones, urinary incontinence, and urological cancers has created a high demand for devices and treatments in nephrology and urology. This trend drives market growth during the nephrology and urology devices market analysis period. Furthermore, ongoing innovations in medical devices, such as minimally invasive surgical instruments, robotic-assisted surgeries, and improved diagnostic tools, have enhanced patient outcomes and boosted market growth. For example, Fresenius Medical Care's 6008 Series Hemodialysis Machines offer advanced features for precise dialysis treatment, enhancing the overall dialysis experience for both patients and healthcare providers. These advancements have fueled the growth of the nephrology and urology devices market. However, the high cost of urology devices negatively impacts market growth, particularly in price-sensitive regions such as Asia-Pacific. The high cost of urology endoscopes and endovision systems may hamper market growth. In addition, the lack of skilled professionals to operate and maintain urology devices is a significant factor that may restrain market growth.

The key regions considered for the Global Nephrology and Urology Devices Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market in 2023 in terms of revenue. This is primarily due to its advanced healthcare infrastructure, high prevalence of kidney and urinary tract diseases, and significant investment in research and development. The region's well-established healthcare facilities and the availability of skilled healthcare professionals drive the demand for innovative nephrology and urology devices. The United States, in particular, leads the market with its high incidence of chronic kidney disease (CKD) and urological disorders, necessitating advanced treatment options. Additionally, favorable reimbursement policies and strong support from government and private healthcare organizations boost market growth. The presence of major medical device manufacturers and continuous technological advancements further enhance the region's market dominance. Increasing awareness about early diagnosis and treatment of kidney and urinary conditions, along with a growing aging population, also contribute to the rising demand for nephrology and urology devices in North America. Furthermore, Asia Pacific is projected to grow significantly during the forecast period 2024-2032.

Major market players included in this report are:

Medtronic plc
Boston Scientific Corporation
B. Braun SE
Baxter International Inc.
Coloplast
Olympus Corporation
Stryker Corporation
Teleflex Incorporated
Becton, Dickinson and Company
Karl Storz GmbH & Co. KG
STERIS
Advin Health Care
Narang Medical Limited

The detailed segments and sub-segment of the market are explained below:

By Product:

Instruments
Consumables & Accessories

By Application:

Kidney Diseases
Urological Cancer & BPH
Others

By End User:

Hospitals
Dialysis Centers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Nephrology and Urology Devices Market Executive Summary

1.1. Global Nephrology and Urology Devices Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Application
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Nephrology and Urology Devices Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Nephrology and Urology Devices Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)
- 3.1.2. Advancements in medical devices and technologies
- 3.1.3. Increasing awareness about early diagnosis and treatment
3.2. Market Challenges
- 3.2.1. High cost of urology devices
- 3.2.2. Lack of skilled professionals
3.3. Market Opportunities
- 3.3.1. Demand for home-based dialysis solutions
- 3.3.2. Technological innovations in devices

Chapter 4. Global Nephrology and Urology Devices Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Nephrology and Urology Devices Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Nephrology and Urology Devices Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Instruments
- 5.2.2. Consumables and Accessories

Chapter 6. Global Nephrology and Urology Devices Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Nephrology and Urology Devices Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Kidney Diseases
- 6.2.2. Urological Cancer and BPH
- 6.2.3. Others

Chapter 7. Global Nephrology and Urology Devices Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Global Nephrology and Urology Devices Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospitals
- 7.2.2. Dialysis Centers
- 7.2.3. Others

Chapter 8. Global Nephrology and Urology Devices Market Size & Forecasts by Region 2022-2032

8.1. North America Nephrology and Urology Devices Market
- 8.1.1. U.S. Nephrology and Urology Devices Market
  - 8.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Application breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End User breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Nephrology and Urology Devices Market
  - 8.1.2.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.2.2. Application breakdown size & forecasts, 2022-2032
  - 8.1.2.3. End User breakdown size & forecasts, 2022-2032
- 8.1.3. Mexico Nephrology and Urology Devices Market
  - 8.1.3.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.3.2. Application breakdown size & forecasts, 2022-2032
  - 8.1.3.3. End User breakdown size & forecasts, 2022-2032
8.2. Europe Nephrology and Urology Devices Market
- 8.2.1. U.K. Nephrology and Urology Devices Market
  - 8.2.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.2.1.2. Application breakdown size & forecasts, 2022-2032
  - 8.2.1.3. End User breakdown size & forecasts, 2022-2032
- 8.2.2. Germany Nephrology and Urology Devices Market
  - 8.2.2.1. Product breakdown size & forecasts, 2022-2032
  - 8.2.2.2. Application breakdown size & forecasts, 2022-2032
  - 8.2.2.3. End User breakdown size & forecasts, 2022-2032
- 8.2.3. France Nephrology and Urology Devices Market
  - 8.2.3.1. Product breakdown size & forecasts, 2022-2032
  - 8.2.3.2. Application breakdown size & forecasts, 2022-2032
  - 8.2.3.3. End User breakdown size & forecasts, 2022-2032
- 8.2.4. Italy Nephrology and Urology Devices Market
  - 8.2.4.1. Product breakdown size & forecasts, 2022-2032
  - 8.2.4.2. Application breakdown size & forecasts, 2022-2032
  - 8.2.4.3. End User breakdown size & forecasts, 2022-2032
- 8.2.5. Spain Nephrology and Urology Devices Market
  - 8.2.5.1. Product breakdown size & forecasts, 2022-2032
  - 8.2.5.2. Application breakdown size & forecasts, 2022-2032
  - 8.2.5.3. End User breakdown size & forecasts, 2022-2032
- 8.2.6. Rest of Europe Nephrology and Urology Devices Market
  - 8.2.6.1. Product breakdown size & forecasts, 2022-2032
  - 8.2.6.2. Application breakdown size & forecasts, 2022-2032
  - 8.2.6.3. End User breakdown size & forecasts, 2022-2032
8.3. Asia-Pacific Nephrology and Urology Devices Market
- 8.3.1. China Nephrology and Urology Devices Market
  - 8.3.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.3.1.2. Application breakdown size & forecasts, 2022-2032
  - 8.3.1.3. End User breakdown size & forecasts, 2022-2032
- 8.3.2. Japan Nephrology and Urology Devices Market
  - 8.3.2.1. Product breakdown size & forecasts, 2022-2032
  - 8.3.2.2. Application breakdown size & forecasts, 2022-2032
  - 8.3.2.3. End User breakdown size & forecasts, 2022-2032
- 8.3.3. India Nephrology and Urology Devices Market
  - 8.3.3.1. Product breakdown size & forecasts, 2022-2032
  - 8.3.3.2. Application breakdown size & forecasts, 2022-2032
  - 8.3.3.3. End User breakdown size & forecasts, 2022-2032
- 8.3.4. South Korea Nephrology and Urology Devices Market
  - 8.3.4.1. Product breakdown size & forecasts, 2022-2032
  - 8.3.4.2. Application breakdown size & forecasts, 2022-2032
  - 8.3.4.3. End User breakdown size & forecasts, 2022-2032
- 8.3.5. Australia Nephrology and Urology Devices Market
  - 8.3.5.1. Product breakdown size & forecasts, 2022-2032
  - 8.3.5.2. Application breakdown size & forecasts, 2022-2032
  - 8.3.5.3. End User breakdown size & forecasts, 2022-2032
- 8.3.6. Rest of Asia-Pacific Nephrology and Urology Devices Market
  - 8.3.6.1. Product breakdown size & forecasts, 2022-2032
  - 8.3.6.2. Application breakdown size & forecasts, 2022-2032
  - 8.3.6.3. End User breakdown size & forecasts, 2022-2032
8.4. Latin America Nephrology and Urology Devices Market
- 8.4.1. Brazil Nephrology and Urology Devices Market
  - 8.4.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.4.1.2. Application breakdown size & forecasts, 2022-2032
  - 8.4.1.3. End User breakdown size & forecasts, 2022-2032
- 8.4.2. Mexico Nephrology and Urology Devices Market
  - 8.4.2.1. Product breakdown size & forecasts, 2022-2032
  - 8.4.2.2. Application breakdown size & forecasts, 2022-2032
  - 8.4.2.3. End User breakdown size & forecasts, 2022-2032
- 8.4.3. Rest of Latin America Nephrology and Urology Devices Market
  - 8.4.3.1. Product breakdown size & forecasts, 2022-2032
  - 8.4.3.2. Application breakdown size & forecasts, 2022-2032
  - 8.4.3.3. End User breakdown size & forecasts, 2022-2032
8.5. Middle East & Africa Nephrology and Urology Devices Market
- 8.5.1. Saudi Arabia Nephrology and Urology Devices Market
  - 8.5.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.5.1.2. Application breakdown size & forecasts, 2022-2032
  - 8.5.1.3. End User breakdown size & forecasts, 2022-2032
- 8.5.2. South Africa Nephrology and Urology Devices Market
  - 8.5.2.1. Product breakdown size & forecasts, 2022-2032
  - 8.5.2.2. Application breakdown size & forecasts, 2022-2032
  - 8.5.2.3. End User breakdown size & forecasts, 2022-2032
- 8.5.3. Rest of Middle East & Africa Nephrology and Urology Devices Market
  - 8.5.3.1. Product breakdown size & forecasts, 2022-2032
  - 8.5.3.2. Application breakdown size & forecasts, 2022-2032
  - 8.5.3.3. End User breakdown size & forecasts, 2022-2032

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Medtronic plc
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Boston Scientific Corporation
- 9.3.3. B. Braun SE
- 9.3.4. Baxter International Inc.
- 9.3.5. Coloplast
- 9.3.6. Olympus Corporation
- 9.3.7. Stryker Corporation
- 9.3.8. Teleflex Incorporated
- 9.3.9. Becton, Dickinson and Company
- 9.3.10. Karl Storz GmbH & Co. KG
- 9.3.11. STERIS
- 9.3.12. Advin Health Care
- 9.3.13. Narang Medical Limited

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes